Real-time Computer Aided Detection of Barrett's Neoplasia

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
Overall Status
Completed
CT.gov ID
NCT05628441
Collaborator
(none)
30
1
4.9
6.1

Study Details

Study Description

Brief Summary

In the real-time pilot study, the performance of a recently developed Computer Aided Detection (CADe) system will be investigated in 30 patients during real-time live endoscopic examination. Three expert endoscopists in the field of Barrett's esophagus and endoscopic resection techniques will perform the inclusions following a standardized data acquisition protocol. In total, 15 patients with a visible neoplastic lesion in their Barrett's esophagus and 15 patients without any visible abnormalities in their Barrett's esophagus will be included in this study. Outcomes: to investigate feasibility of the use of the CADe system in the endoscopy suite, to investigate the performance of the CADe system when used by endoscopists.

Condition or Disease Intervention/Treatment Phase
  • Other: Computer Aided Detection system for Barrett's neoplasia

Detailed Description

Patients in this study will undergo a scheduled surveillance endoscopy (according to current guidelines; n = 15) or are referred to a tertiary referral center for endoscopic resection of a possible neoplastic area in their known Barrett's esophagus (n = 15).

Patients will be consciously sedated (standard care) before start of the procedure. During the endoscopic procedure, the endoscopist follows the standard protocol after extensive cleaning of the Barrett's segment: first, a standardized pullback video will be recorded, followed by a careful inspection of the Barrett segment every 2 centimeters. Per 2cm, a video of 10 seconds and 3 overview images are being recorded.

During the imaging protocol, the CADe system presents its prediction on a second screen, next to the main endoscopy monitor. After the imaging protocol, standard clinical care is being resumed.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Real-time Computer Aided Detection of Barrett's Neoplasia: a Pilot Study
Actual Study Start Date :
May 16, 2022
Actual Primary Completion Date :
Oct 13, 2022
Actual Study Completion Date :
Oct 13, 2022

Arms and Interventions

Arm Intervention/Treatment
CADe system

All patients included in the study will undergo the endoscopic procedure according to standard clinical care and the study protocol. The CADe system will run in the back, not interfering with care.

Other: Computer Aided Detection system for Barrett's neoplasia
CADe system running in the back, not directly interfering with patient care

Outcome Measures

Primary Outcome Measures

  1. Combined performance of endoscopist + CADe system in terms of per-patient sensitivity and specificity [5 months]

    To investigate the combined performance between endoscopist and CADe system on a per-patient level.

Secondary Outcome Measures

  1. Stand-alone performance of CADe system in terms of per-patient sensitivity and specificity [5 months]

    To investigate the performance of the CADe system on new data on a per-patient level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age > 18 years;

  • Patients under surveillance for their diagnosed non-dysplastic Barrett's esophagus or patients refered for endoscopic treatment because of proven high-grade dysplasia or adenocarcinoma;

  • A circumferential Barrett length of at least 2cm

Exclusion Criteria:
  • Medical history of prior surgical or endoscopical treatment for neoplasia in their esophagus

  • Reflux esophagitis > grade 2 (LA classification)

  • Inability to undergo endoscopic treatment and/or biopsies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Academic Medical Center Amsterdam Netherlands

Sponsors and Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Investigators

  • Principal Investigator: J.J. Bergman, MD PHD, Amsterdam University Medical Centers, location AMC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
prof. dr. J.J.G.H.M. Bergman, Professor of Gastroenterology, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ClinicalTrials.gov Identifier:
NCT05628441
Other Study ID Numbers:
  • 2021.0269
First Posted:
Nov 28, 2022
Last Update Posted:
Nov 28, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by prof. dr. J.J.G.H.M. Bergman, Professor of Gastroenterology, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 28, 2022